Sign in

CIK 0001652130

  • Large accelerated filer

Intellia Therapeutics, Inc.

Sign in to watch
Ticker
NTLA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
364785571
Phone
+1 857-285-6200
Business address
400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$167,285
in 3 filings, $144K under 10b5-1 plans

Net −$167,285. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-09-01 LEONARD JOHN M. President and CEO Exercise or conversion +5,000 $6.83 $34K 472,352
2020-09-01 LEONARD JOHN M. President and CEO Sale −5,000 $21.83 $109K 467,352
2020-09-01 LEONARD JOHN M. President and CEO Exercise or conversion · Stock Option (right to buy) −5,000 330,234
2020-08-06 LEONARD JOHN M. President and CEO Exercise or conversion +5,000 $6.83 $34K 472,352
2020-08-06 LEONARD JOHN M. President and CEO Sale −5,000 $21.83 $109K 467,352
2020-08-06 LEONARD JOHN M. President and CEO Exercise or conversion · Stock Option (right to buy) −5,000 335,234
2020-07-01 LEONARD JOHN M. President and CEO Exercise or conversion +5,000 $6.83 $34K 472,352
2020-07-01 LEONARD JOHN M. President and CEO Sale −5,000 $21.83 $109K 467,352
2020-07-01 LEONARD JOHN M. President and CEO Exercise or conversion · Stock Option (right to buy) −5,000 340,234
2020-06-03 LEONARD JOHN M. President and CEO Exercise or conversion +5,000 $6.83 $34K 472,352
2020-06-03 LEONARD JOHN M. President and CEO Sale −5,000 $21.83 $109K 467,352
2020-06-03 LEONARD JOHN M. President and CEO Exercise or conversion · Stock Option (right to buy) −5,000 345,234
2020-03-02 LEONARD JOHN M. President and CEO Grant or award · Stock Option (Right to Buy) +340,000 340,000
2018-12-18 LEONARD JOHN M. President and CEO Grant or award · Stock Option (right to buy) +240,000 240,000
2018-05-14 LEONARD JOHN M. President and CEO Sale −8,400 $24.00 $202K 0
2018-01-25 LEONARD JOHN M. CEO Grant or award · Stock Option (right to buy) +220,000 220,000
2017-12-12 LEONARD JOHN M. EVP, R&D Grant or award · Stock Option (right to buy) +72,500 72,500
2017-06-01 LEONARD JOHN M. EVP, R&D Grant or award +7,800 $12.06 $94K 7,800
2017-06-01 LEONARD JOHN M. EVP, R&D Grant or award +600 $12.09 $7K 8,400
2017-01-06 LEONARD JOHN M. EVP, R&D Grant or award · Stock Option (right to buy) +95,000 95,000

Page 1 of 1 · 20 trades